Allergan makes case against Valeant takeover ahead of higher bid

J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec May 20, 2014.



Credit: Reuters/Christinne Muschi

via Smart Health Shop Forum http://ift.tt/1oHDmYY